Form 4 for DRMA Dermata Therapeutics, Inc.
Accepted 2021-08-17 00:00:00 ET · period of report 2021-08-17 · accession 0000905718-21-001112 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2021-08-17 | 2021-08-17 | DRMA | Bedoya-Toro Munera Maria E | SVP | C - Cnv Deriv | — | +64.6K | 84.1K | +331% | — |
| DMI | 2021-08-17 | 2021-08-17 | DRMA | Bedoya-Toro Munera Maria E | SVP | C - Cnv Deriv | $0.00 | -1.29M | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-17 | C | A | 9,162 | — | 28,674 | I By Munera Family Trust | — | — | (F1) The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date. (F7) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| 2 | Common | Common Stock | 2021-08-17 | C | A | 19,512 | — | 48,186 | I By Munera Family Trust | — | — | (F2) The Series 1a Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1a Preferred Stock was convertible at any time and had no expiration date. (F7) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| 3 | Common | Common Stock | 2021-08-17 | C | A | 4,878 | — | 53,064 | I By Munera Family Trust | — | — | (F3) The Series 1b Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1b Preferred Stock was convertible at any time and had no expiration date. (F7) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| 4 | Common | Common Stock | 2021-08-17 | C | A | 17,421 | — | 70,485 | I By Munera Family Trust | — | — | (F4) The Series 1c Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1c Preferred Stock was convertible at any time and had no expiration date. (F7) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| 5 | Common | Common Stock | 2021-08-17 | C | A | 13,658 | — | 84,143 | I By Munera Family Trust | — | — | (F5) The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1 Preferred Stock was convertible at any time and had no expiration date. (F7) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| 6 | Derivative | Series 1d Preferred Stock | 2021-08-17 | C | D | 61,821 | $0.00 | 0 | I By Munera Family Trust | — · — to — | 9,162 Common Stock | (F7) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F1) The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date. |
| 7 | Derivative | Series 1a Preferred Stock | 2021-08-17 | C | D | 400,000 | $0.00 | 0 | I By Munera Family Trust | — · — to — | 19,512 Common Stock | (F7) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F2) The Series 1a Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1a Preferred Stock was convertible at any time and had no expiration date. |
| 8 | Derivative | Series 1b Preferred Stock | 2021-08-17 | C | D | 100,000 | $0.00 | 0 | I By Munera Family Trust | — · — to — | 4,878 Common Stock | (F7) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F3) The Series 1b Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1b Preferred Stock was convertible at any time and had no expiration date. |
| 9 | Derivative | Warrant to Purchase Common Stock | 2021-08-17 | C | A | 4,878 | $0.00 | 4,878 | I By Munera Family Trust | $20.50 · 2016-11-15 to 2026-03-14 | 4,878 Common Stock | (F7) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| 10 | Derivative | Series 1 Preferred Stock | 2021-08-17 | C | D | 280,000 | $0.00 | 0 | I By Munera Family Trust | — · — to — | 13,658 Common Stock | (F7) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F5) The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1 Preferred Stock was convertible at any time and had no expiration date. |
| 11 | Derivative | Series 1a Warrants | 2021-08-17 | C | D | 100,000 | $0.00 | 0 | I By Munera Family Trust | — · 2016-11-15 to 2026-03-14 | 4,878 Common Stock | (F7) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F6) The Series 1a Preferred Warrants converted into warrants to purchase Common Stock in connection with the IPO. |
| 12 | Derivative | Series 1c Preferred Stock | 2021-08-17 | C | D | 357,142 | $0.00 | 0 | I By Munera Family Trust | — · — to — | 17,421 Common Stock | (F7) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F4) The Series 1c Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1c Preferred Stock was convertible at any time and had no expiration date. |